Mental Health Clinics in Clinton, OH Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 New Destiny Treatment Center Mental Health And Special Services Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6694 Taylor Rd, Clinton, OH 44216 Phone: 330-825-5202 Fax: 330-825-5113 |
New Destiny Treatment Center, Inc. Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6694 Taylor Rd, Clinton, OH 44216 Phone: 330-825-5202 Fax: 330-825-5113 |
News Archive
Chewing gum helps recovery from gastrointestinal surgery
In an article recently recommended by Bradley Kropp of Faculty of 1000 Medicine, researchers find chewing gum is a simple solution to the recovery of bowel function after gastrointestinal surgery – a problem that has troubled patients and physicians for decades.
First Edition: October 24, 2011
Today's headlines include a variety of health policy news developments, including speculation about how the Supreme Court might review the health law and what's happening with the super committee.
Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
With panelists now in place, possible dynamics of a deal emerge
The special committee that will have to find $1.5 trillion in budget savings has a few members who will understand exactly what's at stake for Medicare and Medicaid. But others will only have a general idea — and it may be completely shaped by their political interests. Some of them won't have much of a health care background at all, but will have to get up to speed quickly.
FDA Advisory Committee votes against the approval of Tarceva
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 2 days ago